Haymaker Acquisition Corp. III
Status: Closed Deal
U=S+W/4
W=S@11.5
| IPO Proceeds, $M | $317.50M |
|---|---|
| IPO Date | Mar 2, 2021 |
| CEO | Steven J. Heyer |
| Left Lead | Citigroup |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Consumer ▶ |
| IPO Geography | US/Canada |
| Target Company | BioTE Holdings |
| Deal Announced | Dec 13, 2021 |
| Deal Size, $M | $667.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | May 24, 2022 |
| Amendment Vote | TBD |
| Closing Date | May 26, 2022 |
Formerly HYAC
BTMD
BTMDW
| Price | $3.54 |
|---|---|
| Last closing price | $3.47 |
| H/L, today | $3.42 / $3.57 |
| H/L, 52-week | $2.75 / $8.22 |
| Volume, today | 77,324 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.